Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Shah Pratik Create: Alert

All | News | Filings
Date FiledTypeDescription
06/28/2023 4 Shah Pratik (10% Owner) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 40,000 options to buy @ $6.5, valued at $260k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/10/2022 4 Shah Pratik (10% Owner) has filed a Form 4 on ARS Pharmaceuticals, Inc.
Txns: Granted 10,156,204 shares @ $0
Granted 354,570 options to buy @ $1.44, valued at $510.6k
02/02/2022 4 Shah Pratik (Executive Chairperson) has filed a Form 4 on Design Therapeutics, Inc.
Txns: Granted 475,000 options to buy @ $12.77, valued at $6.1M
04/01/2021 4 Shah Pratik (Executive Chairperson) has filed a Form 4 on Design Therapeutics, Inc.
Txns: Bought 25,000 shares @ $20, valued at $500k
Converted 104,923 shares @ $0
Converted 171,025 preferred shares @ $0
01/24/2020 4 Shah Pratik (Director) has filed a Form 4 on Synthorx, Inc.
Txns: Unknown transaction of 62,412 shares @ $68, valued at $4.2M
Disposed/sold 10,223 options to buy @ $12.4, valued at $126.8k
06/10/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2015 4 Shah Pratik (President and CEO) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns: Unknown transaction of 903,018 shares @ $0
Disposed/sold 215,153 options to buy @ $6.57, valued at $1.4M
Disposed/sold 200,000 options to buy @ $59.66, valued at $11.9M
Disposed/sold 100,000 restricted stock units @ $0
02/04/2015 4 Shah Pratik (President and CEO) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns: Granted 200,000 options to buy @ $59.66, valued at $11.9M
Granted 100,000 restricted stock units @ $0
02/12/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
12/23/2013 4 Shah Pratik (Director) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $7.85, valued at $157k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy